Skip to main content

Passion, Purpose, And Why Traders Fail



There are four overarching themes in the Trading Psychology 2.0 book that account for success in financial markets: 

*  Adapting to changing markets;
*  Building on strengths
*  Cultivating creativity
*  Developing best practices and processes

These ABCD themes are interwoven:  we adapt to changing markets by becoming more creative and generating new and better trade ideas.  We build on our strengths and channel those into best practices.  By continually learning from our trading successes and setbacks, we refine our best practices, build on our strengths, and adapt to market conditions.

Many traders fail because they are playing the wrong game.  They pursue trading by following others, not by exercising their strengths.  They insist that trading is their interest and passion, but there is little energy in their attitude and no creative spark.  We experience excitement and interest when we play to our strengths: the exercise of strengths is intrinsically rewarding.  When traders veer from their strengths and attempt to make money in ways that don't match their personality or cognitive styles, trading becomes inherently frustrating.

What is our life's purpose?  We don't always know what we're meant to be doing during our time on this earth, but our passions--the deep, intrinsic fulfillments that come from exercising strengths--point the way to our purposes.  In previous writing, I shared that I pursued full time trading a little over a decade ago.  I made progress, I made money--and I was wholly unfulfilled.  Indeed, I found myself chatting with traders more than trading, and I missed quite a few trades that way!  Why?  Because my greatest passion--and my greatest strengths--lie in working with people.  I became a psychologist for a reason.  Doing well in markets is rewarding, but--for me--couldn't replace the deep reward of becoming a valuable resource in another person's development.

I've met longer time frame traders who came to shops where risk was managed quite tightly.  The risk management constraints nudged them to shorter holding periods and turned them from investors to traders.  But their strengths were analytical and thematic, not based in rapid pattern recognition and decision-making.  Slowly, they stopped enjoying their work; they stopped working as hard; and they lost the energy and drive that had experienced in their earlier trading.  They were playing the wrong game.

If you're not finding fulfillment in your trading, consider the possibility that you are trying to fit into trading rather than make trading an exercise of your deepest interests, talents, and skills.  Consider, too, the possibility that your greatest fulfillment and exercise of strengths may lie outside financial markets.  If you are honest with yourself and follow your true passions--your deepest gratification--you're most likely to find your purpose.  You're meant to be the person you are when you're truly at your best.

Further Reading:  Our Struggles Develop Our Strengths

Note:  Throughout my writing of this post, Mia has been on my desk, at my side, nuzzling and licking my left hand.  It is difficult to type when a cat is rubbing against your hand, but the ideas flow much more quickly.  It's yet another way that our passions fuel our creativity--and our happiness.
.

Comments

Popular posts from this blog

Austerity-A Fancy Word for Destitute.

The reason for this post is not for the folks who have been caught in the first wave of personal economic hard reality, but the next wave. Regardless of the optimism espoused by grinning leaders and sycophant press, we are entering the final stage of global economic collapse. It began in 2008 and was forestalled for five years with fudge putty, but the weight of global indebtedness cannot be propped any longer and the final crunch is imminent. Austerity measures herald the final throes.  Indications of coming austerity.   Austerity measures are the final last ditch effort, futile or not! Back in the day many of us old-timers went through periods of "hard-times". In retrospect I realize there is no comparison to yesteryear hard times and today's version. Back then, expectations were never very high for the working class, there were no sophisticated systems or conveniences anyway. In fact the difference between being "set" or not was about having treats or not. Si...

Terrifying Arctic methane levels

A peak methane level of 3026 ppb was recorded by the MetOp-B satellite at 469 mb on December 11, 2021 am. This follows a peak methane level of  3644 ppb  recorded by the MetOp-B satellite at 367 mb on November 21, 2021, pm. A peak methane level of 2716 ppb was recorded by the MetOp-B satellite at 586 mb on December 11, 2021, pm, as above image shows. This image is possibly even more terrifying than the image at the top, as above image shows that at 586 mb, i.e. much closer to sea level, almost all methane shows up over sea, rather than over land, supporting the possibility of large methane eruptions from the seafloor, especially in the Arctic.  Also, the image was recorded later than the image at the top with the 3026 ppb peak, indicating that even more methane may be on the way. This appears to be confirmed by the Copernicus forecast for December 12, 2021, 03 UTC, as illustrated by the image below, which shows methane at 500 hPa (equivalent to 500 mb). Furthermore, ...

Women and children overboard

It's the  Catch-22  of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations,"  like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans."  Action began on that, too. There is still a long way to go. But this month there was a sign that ...